The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 307.40
Bid: 306.40
Ask: 306.60
Change: 17.60 (6.07%)
Spread: 0.20 (0.065%)
Open: 296.00
High: 308.70
Low: 295.50
Prev. Close: 289.80
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Key findings from Phase 2 of Travers Smith review

15 Dec 2023 09:00

RNS Number : 9689W
NatWest Group plc
15 December 2023

Key findings from Phase 2 of Travers Smith review

NatWest Group (NWG) has today published the key findings and recommendations from Phase 2 of the Travers Smith independent review - commissioned by the Board in July - relating to account closures at Coutts over the 24-month period prior to 28 July 2023.

The key findings and recommendations report (the report) published today was compiled by Travers Smith. The Phase 2 review analysed 84 customer account closures - including all relevant PEP cases exited over the relevant period - building a total sample of around 10% of relevant account closures in the period.

The report confirms that decision-making was consistent with relevant standards and otherwise appropriate and that there was no evidence of discrimination due to political views or affiliations, or any other protected characteristic. However, it identifies several areas where Coutts' policies and procedures governing exit decisions could be improved, including the process by which exit decisions are communicated to customers and the clarity of communications.

NatWest Group has accepted - and will implement - all the recommendations contained in Phases 1 and 2 of the review.

Commenting on the report, Mohammad Syed, Chief Executive of Coutts, said:

"Following the publication of the Phase 1 reports in October, we recognised the need to improve our customer account closure processes and those improvements are already well under way. Although Travers Smith confirm that, in general, decisions were appropriate and that there was no evidence of discrimination, it is clear there are lessons to be learned. This report reaffirms that there were a number of shortcomings in our approach to account closures at Coutts and, in particular, in the quality and consistency of our communications. The experience of some of our customers fell short of what they should expect, and we apologise to them.

"We are committed to implementing all of the recommendations made by Travers Smith, including comprehensively reviewing and updating exit and communication processes, so that we deliver a better, more consistent experience for all our customers."

The report sets out Travers Smith's key findings and recommendations in full

https://www.natwestgroup.com/content/dam/natwestgroup_com/natwestgroup/pdf/Travers-Smith-Phase-2-Key-Findings-Recommendations.pdf

In summary, the Phase 2 findings include:

i. Decision-making: in general, exit decisions were made in accordance with relevant bank policies and processes and there was no evidence of discrimination due to political views or affiliations, or any other protected characteristic. Decision-making by Coutts in relation to the exit cases was consistent with relevant standards and otherwise appropriate. However, Travers Smith found that policies and procedures governing exit decisions could be improved in some areas.

ii. Exit processes: there is little by way of formal procedure or process governing how non-financial crime exits must be carried out by Coutts staff, and there is no formalised set of definitions for the potential bases for exit or guidance on thresholds to be met for a customer to be exited. Travers Smith also found that:

? In some exit cases, there were deficiencies in the internal process followed, and in the content or format of the exit letter or the process by which that letter was conveyed to the customer;

? In a small number of cases, by not communicating at least 60 days' notice of account closure to the customer, Coutts potentially breached Regulation 51(4) of the Payment Services Regulations; and

? Primarily in relation to the failure by Coutts to provide reasons for exits, Coutts potentially breached FCA rules, including the obligation to treat customers fairly.

iii. Data protection analysis: the report identified some potential compliance failures and/or best practice shortcomings in Coutts' data processing in respect of exit decisions. The report also contains a summary of Travers Smith's data protection analysis relating to Phase 1 of the Travers Smith independent review.

In light of the recommendations made by Travers Smith, and its own internal work, NatWest Group is taking action to ensure better outcomes and experiences for customers across the bank. The key steps include:

1. Reviewing and updating exit processes, including a review of exit letters and the introduction of a commercial exits framework that provides customers with the opportunity to improve their economic contribution where appropriate;

2. The establishment of a new franchise exits process and an appropriate PEP declassification programme; and

3. Refreshed guidance and mandatory training on the complaints process will be issued to the front line, Coutts 24 and all relevant senior leaders.

In October, the FCA confirmed that it is undertaking a programme of supervisory work with NatWest Group and Coutts. NatWest Group will continue to work with its peers and regulators and with the UK Government so that it is easier for banks to communicate clearly with customers who are being exited.

--ENDS--

For more information, please contact:

NatWest Group Investor RelationsAlexander HolcroftHead of Investor Relations+44 20 7672 1758

NatWest Group Media Relations

+44(0)131 523 4205

Legal Entity Identifier: 2138005O9XJIJN4JPN90

This document may include forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'will', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as NatWest Group's future economic results, business plans and strategies. In particular, this document may include forward-looking statements relating to NatWest Group plc in respect of, but not limited to: its economic and political risks, its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital, cost savings and operational targets), the implementation of its purpose-led strategy, its environmental, social and governance and climate related targets, its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, the transition of LIBOR and IBOR rates to replacement risk free rates and NatWest Group's exposure to operational risk, conduct risk, cyber, data and IT risk, financial crime risk, key person risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest Group plc's actual results are discussed in NatWest Group plc's 2022 Annual Report on Form 20-F, NatWest Group plc's Interim Results for H1 2023 on Form 6-K, Natwest Group plc's Interim Management Statement for Q1 and Q3 2023 on Form 6-K, and its other public filings. The forward-looking statements contained in this document speak only as of the date of this document and NatWest Group plc does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDKZMMZNKRGFZG
Date   Source Headline
26th Apr 20245:54 pmRNSPublication of Supplementary Prospectus
26th Apr 202410:30 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSNWG plc Q1 2024 Interim Management Statement
25th Apr 20245:15 pmRNSTransaction in Own Shares
24th Apr 20245:16 pmRNSTransaction in Own Shares
23rd Apr 20245:22 pmRNSTransaction in Own Shares
23rd Apr 20242:22 pmRNSResult of AGM
23rd Apr 20242:02 pmRNSDividend Declaration
23rd Apr 202411:01 amRNSAGM Statement
19th Apr 20245:27 pmRNSTransaction in Own Shares
18th Apr 20245:54 pmRNSTransaction in Own Shares
17th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:15 pmRNSTransaction in Own Shares
12th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 20245:10 pmRNSTransaction in Own Shares
11th Apr 202411:43 amRNSBlock Listing Six Monthly Return
10th Apr 20245:15 pmRNSTransaction in Own Shares
9th Apr 20245:20 pmRNSTransaction in Own Shares
8th Apr 20245:35 pmRNSTransaction in Own Shares
5th Apr 202410:32 amRNSHolding(s) in Company - HMT shareholding
4th Apr 20245:39 pmRNSTransaction in Own Shares
4th Apr 20248:00 amRNSDirector Declaration
3rd Apr 20245:13 pmRNSTransaction in Own Shares
3rd Apr 20242:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20246:04 pmRNSTransaction in Own Shares
28th Mar 20245:17 pmRNSTransaction in Own Shares
28th Mar 20241:55 pmRNSTotal Voting Rights
27th Mar 20245:31 pmRNSTransaction in Own Shares
27th Mar 20244:21 pmRNSHolding(s) in Company
25th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 202410:30 amRNSHolding(s) in Company - HMT shareholding
22nd Mar 20245:47 pmRNSTransaction in Own Shares
22nd Mar 20249:30 amRNSDirector Declaration
21st Mar 20245:49 pmRNSTransaction in Own Shares
20th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 20245:47 pmRNSTransaction in Own Shares
19th Mar 20249:01 amRNSHoldings in Company
18th Mar 20245:45 pmRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSNotice of AGM
18th Mar 202412:00 pmRNSDirector/PDMR Shareholding
15th Mar 20245:32 pmRNSTransaction in Own Shares
15th Mar 202410:19 amRNSHolding(s) in Company - HMT shareholding
14th Mar 20245:48 pmRNSTransaction in Own Shares
13th Mar 20245:13 pmRNSTransaction in Own Shares
12th Mar 20245:08 pmRNSTransaction in Own Shares
11th Mar 20245:39 pmRNSTransaction in Own Shares
8th Mar 20245:14 pmRNSTransaction in Own Shares
8th Mar 20242:15 pmRNSDirector/PDMR Shareholding
8th Mar 202412:41 pmRNSHolding(s) in Company
7th Mar 20245:26 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.